Ameriprise’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-476,318
| Closed | -$12M | – | 4137 |
|
|
2025
Q3 | $12M | Sell |
476,318
-401,273
| -46% | -$10.1M | ﹤0.01% | 1770 |
|
|
2025
Q2 | $22.1M | Sell |
877,591
-201,942
| -19% | -$5.07M | 0.01% | 1288 |
|
|
2025
Q1 | $27.2M | Sell |
1,079,533
-496,406
| -31% | -$12.5M | 0.01% | 1142 |
|
|
2024
Q4 | $39.5M | Sell |
1,575,939
-77,804
| -5% | -$1.95M | 0.01% | 957 |
|
|
2024
Q3 | $41.4M | Sell |
1,653,743
-50,695
| -3% | -$1.27M | 0.01% | 930 |
|
|
2024
Q2 | $42.3M | Sell |
1,704,438
-3,821
| -0.2% | -$94.7K | 0.01% | 878 |
|
|
2024
Q1 | $42.4M | Buy |
1,708,259
+116,986
| +7% | +$2.9M | 0.01% | 884 |
|
|
2023
Q4 | $39M | Sell |
1,591,273
-450,405
| -22% | -$11M | 0.01% | 890 |
|
|
2023
Q3 | $49.7M | Buy |
2,041,678
+747,584
| +58% | +$18.2M | 0.02% | 740 |
|
|
2023
Q2 | $31.5M | Buy |
1,294,094
+94,659
| +8% | +$2.32M | 0.01% | 995 |
|
|
2023
Q1 | $29.4M | Sell |
1,199,435
-231,920
| -16% | -$5.67M | 0.01% | 1020 |
|
|
2022
Q4 | $34.8M | Buy |
1,431,355
+255,640
| +22% | +$6.19M | 0.01% | 893 |
|
|
2022
Q3 | $28.4M | Buy |
1,175,715
+296,186
| +34% | +$7.31M | 0.01% | 964 |
|
|
2022
Q2 | $21.7M | Buy |
879,529
+389,561
| +80% | +$9.7M | 0.01% | 1163 |
|
|
2022
Q1 | $12.4M | Buy |
489,968
+118,874
| +32% | +$3.07M | ﹤0.01% | 1736 |
|
|
2021
Q4 | $9.8M | Buy |
371,094
+31,138
| +9% | +$828K | ﹤0.01% | 1996 |
|
|
2021
Q3 | $9.13M | Buy |
339,956
+24,633
| +8% | +$664K | ﹤0.01% | 1926 |
|
|
2021
Q2 | $8.51M | Buy |
315,323
+11,832
| +4% | +$319K | ﹤0.01% | 2059 |
|
|
2021
Q1 | $8.15M | Buy |
303,491
+10,098
| +3% | +$273K | ﹤0.01% | 2041 |
|
|
2020
Q4 | $8.03M | Buy |
293,393
+14,135
| +5% | +$384K | ﹤0.01% | 1920 |
|
|
2020
Q3 | $7.58M | Buy |
279,258
+7,287
| +3% | +$198K | ﹤0.01% | 1767 |
|
|
2020
Q2 | $7.37M | Buy |
271,971
+7,195
| +3% | +$189K | ﹤0.01% | 1771 |
|
|
2020
Q1 | $6.61M | Buy |
264,776
+43,543
| +20% | +$1.12M | ﹤0.01% | 1703 |
|
|
2019
Q4 | $5.74M | Buy |
221,233
+4,452
| +2% | +$115K | ﹤0.01% | 2154 |
|
|
2019
Q3 | $5.57M | Sell |
216,781
-83,346
| -28% | -$2.14M | ﹤0.01% | 2136 |
|
|
2019
Q2 | $7.69M | Buy |
300,127
+96,378
| +47% | +$2.41M | ﹤0.01% | 1924 |
|
|
2019
Q1 | $5.06M | Buy |
203,749
+130,949
| +180% | +$3.18M | ﹤0.01% | 2222 |
|
|
2018
Q4 | $1.72M | Buy |
72,800
+5,784
| +9% | +$137K | ﹤0.01% | 2715 |
|
|
2018
Q3 | $1.6M | Sell |
67,016
-7,497
| -10% | -$180K | ﹤0.01% | 2892 |
|
|
2018
Q2 | $1.78M | Buy |
74,513
+2,251
| +3% | +$53.9K | ﹤0.01% | 2778 |
|
|
2018
Q1 | $1.75M | Buy |
72,262
+10,462
| +17% | +$256K | ﹤0.01% | 2736 |
|
|
2017
Q4 | $1.55M | Buy |
61,800
+16,827
| +37% | +$422K | ﹤0.01% | 2785 |
|
|
2017
Q3 | $1.13M | Buy |
44,973
+31,564
| +235% | +$793K | ﹤0.01% | 2905 |
|
|
2017
Q2 | $332K | Buy |
+13,409
| New | +$334K | ﹤0.01% | 3380 |
|
Other funds holding IBDQ
Ameriprise's IBDQ Position: Q4 2025 in Review
Ameriprise sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 476,318 shares — an estimated $12M sold.
Ameriprise first reported a position in IBDQ in Q2 2017 and held it in 34 quarters. The position peaked at $49.7M in Q3 2023. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.
- Ameriprise reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
- Ameriprise sold 476,318 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $12M.
- Ameriprise first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q2 2017 and held it in 34 quarters.
- Ameriprise's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $49.7M in Q3 2023.
- 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.
Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.